Effect of atogepant on Migraine-Specific Quality of Life Questionnaire and Headache Impact Test-6 in a 12-week, doubleblind, randomized, phase 3 (PROGRESS) trial for preventive treatment of chronic migraine (CM)
CEPHALALGIA（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要